|Last Price||Today's Change||52-Week Range||Trading Volume|
|47.32||-0.06 (-0.13%)||46.01 - 56.73||7.8 million (Above Avg)|
Market data as of 4:02PM 09/22/14. Quotes are delayed by at least 15 min.
GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)
08/26/2014 3:52 PM ET
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
08/25/2014 9:00 AM ET